Azenta Life Science, headquartered in the United States, is a leading provider in the life sciences industry, specialising in sample management and genomic services. Founded in 2021, the company has quickly established itself as a key player, offering innovative solutions that streamline research and development processes for biopharmaceutical and academic institutions. With a focus on biobanking, sample logistics, and genomic analysis, Azenta Life Science distinguishes itself through its advanced technology and commitment to quality. The company’s core services include automated sample storage, data management, and comprehensive genomic services, all designed to enhance efficiency and accuracy in scientific research. Recognised for its robust market position, Azenta Life Science continues to achieve significant milestones, contributing to advancements in personalised medicine and drug discovery. Its dedication to innovation and customer satisfaction solidifies its reputation as a trusted partner in the life sciences sector.
How does Azenta Life Science's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Azenta Life Science's score of 53 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Azenta Life Sciences reported total carbon emissions of approximately 4,147,000 kg CO2e for Scope 1 and about 9,989,000 kg CO2e for Scope 2. This reflects a decrease from 2023, where emissions were approximately 4,513,000 kg CO2e for Scope 1 and about 10,565,000 kg CO2e for Scope 2. The company has set ambitious targets to reduce its greenhouse gas emissions, committing to a 55% reduction in Scope 1 and Scope 2 emissions by 2033, using 2022 as the baseline year. The emissions data indicates a focus on both mobile and stationary combustion, with significant contributions from fugitive emissions. Azenta is also committed to achieving net-zero emissions across all scopes by 2050, as part of its long-term climate strategy. This commitment aligns with the Science Based Targets initiative (SBTi), which has recognised Azenta's targets as part of its climate action framework. Overall, Azenta Life Sciences is actively working towards substantial emissions reductions while maintaining transparency in its reporting and commitments to sustainability.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 4,647,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 13,492,000 | 00,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Azenta Life Science has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Azenta Life Science's sustainability data and climate commitments